DrugOct 9, 2019
KRS Global Biotechnology Methylcobalamin 30 mL Vial-For SC / IM / IV Use, 30 mg / 30 mL recall — FDA D-0073-2020
Lack of Assurance of Sterility
Class IIFDA: TerminatedKRS Global Biotechnology, Inc.
10,685drug recall records
953FDA Class I records
8firms with 5+ records
Aidapak Services, LLC537 records
Database records
Records — page 167
10,685 detailed records are currently available in this category.
DrugOct 9, 2019
KRS Global Biotechnology Cyclopentolate HCl 1% (5 mg/0.5 mL) / Phenylephrine HCl 2.5% recall — FDA D-0106-2020
Lack of Assurance of Sterility
Class IIFDA: TerminatedKRS Global Biotechnology, Inc.
DrugOct 9, 2019
KRS Global Biotechnology SUCCinylcholine Chloride (PF), 200 mg/10 mL (20 mg/mL), 10 mL Fill recall — FDA D-0105-2020
Lack of Assurance of Sterility
Class IIFDA: TerminatedKRS Global Biotechnology, Inc.
DrugOct 9, 2019
Torrent Pharma Losartan Potassium Tablets, USP 100 mg, [90 or 1000] tablets per bottle recall — FDA D-0122-2020
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 9.82 parts per…
Class IIFDA: OngoingTorrent Pharma Inc.
DrugOct 2, 2019
Shire Human Genetic Therapies Natpara (parathyroid hormone) for Injection, 25 mcg/dose, 2 recall — FDA D-0035-2020
Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing
Class IFDA: TerminatedShire Human Genetic Therapies, Inc.
DrugOct 2, 2019
Shire Human Genetic Therapies Natpara (parathyroid hormone) for Injection, 100 mcg, 2 pack recall — FDA D-0038-2020
Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing
Class IFDA: TerminatedShire Human Genetic Therapies, Inc.
DrugOct 2, 2019
Zarontin recall — FDA D-0002-2020
Labeling: Incorrect or Missing Lot and/or Exp Date. The expiry date on the product label is incorrect. The label states an expiry date of 09/2021 when it should be 09/2020.
Class IIIFDA: TerminatedPfizer Inc.
DrugOct 2, 2019
EPI Health minolira recall — FDA D-0120-2020
Failed Dissolution Specifications:
Class IIIFDA: TerminatedEPI Health, LLC
DrugOct 2, 2019
Akorn Lidocaine Hydroclhoride Jelly USP, 2%, 30 mL tubes recall — FDA D-1878-2019
cGMP Deviations: firm reported finding metal particulate matter in the filling room near the tube feeder during the filling operation of the product. No particulates were identified in the…
Class IIFDA: TerminatedAkorn, Inc.
DrugOct 2, 2019
Pfizer ethosuximide capsules, USP, 250 mg, 100-count bottle recall — FDA D-0001-2020
Labeling: Incorrect or Missing Lot and/or Exp Date. The expiry date on the product label is incorrect. The label states an expiry date of 09/2021 when it should be 09/2020.
Class IIIFDA: TerminatedPfizer Inc.
DrugOct 2, 2019
Shire Human Genetic Therapies Natpara (parathyroid hormone) for Injection, 75 mcg, 2 pack recall — FDA D-0037-2020
Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing
Class IFDA: TerminatedShire Human Genetic Therapies, Inc.
DrugOct 2, 2019
Shire Human Genetic Therapies Natpara (parathyroid hormone) for Injection, 50 mcg, 2 pack recall — FDA D-0036-2020
Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing
Class IFDA: TerminatedShire Human Genetic Therapies, Inc.
DrugOct 2, 2019
Darmerica Quinacrine Dihydrochloride (98.25%), bulk API product recall — FDA D-0125-2020
Label Mix-Up: Product labeled as Quinacrine Dihydrochloride; however, after testing, identified as Artemisinin.
Class IFDA: TerminatedDarmerica, LLC
DrugOct 2, 2019
Nucala (mepolizumab) Injection, 100 mg/mL Prefilled Syringe, Single-Dose, For subcutaneous recall — FDA D-1876-2019
Temperature Abuse; Product stored and shipped outside of labeled storage requirements.
Class IIFDA: TerminatedCardinal Health dba Specialty Pharmaceutical Services
DrugSep 25, 2019
Ridge Properties PRE-TAT (lidocaine) 3 in 1 Pre Tattoo Prep With Lidocaine Liquid Gel, 4% recall — FDA D-1857-2019
Microbial Contamination of Non-Sterile Products: products were found to be contaminated and above specification for lidocaine assay.
Class IIFDA: TerminatedRidge Properties, LLC
DrugSep 25, 2019
Ridge Properties Superior Pain & Itch Relief (lidocaine) Liquid Gel, 4% recall — FDA D-1859-2019
Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.
Class IIFDA: TerminatedRidge Properties, LLC
DrugSep 25, 2019
Anagrelide Capsules, USP, 0.5 mg, 100-count bottle recall — FDA D-1862-2019
Failed Impurities/Degradation Specifications: High Out Of Specification results for impurities detected during routine stability testing.
Class IIFDA: TerminatedTorrent Pharma Inc.
DrugSep 25, 2019
Ridge Properties PRE-TAT (lidocaine) 3 in 1 Pre Tattoo Prep With Lidocaine Cream, 4% recall — FDA D-1856-2019
Microbial Contamination of Non-Sterile Products: products were found to be contaminated and above specification for lidocaine assay.
Class IIFDA: TerminatedRidge Properties, LLC
DrugSep 25, 2019
Ridge Properties Soothing Sore Relief (lidocaine) Liquid Gel, 4% recall — FDA D-1861-2019
Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.
Class IIFDA: TerminatedRidge Properties, LLC
DrugSep 25, 2019
Ridge Properties Soothing Sore Relief (lidocaine) Cream, 4% recall — FDA D-1860-2019
Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.
Class IIFDA: TerminatedRidge Properties, LLC
DrugSep 25, 2019
Aurolife Pharma Allergy Relief recall — FDA D-1865-2019
Failed Impurities/Degradation Specifications
Class IIFDA: TerminatedAurolife Pharma, LLC
DrugSep 25, 2019
Ridge Properties Superior Pain & Itch Relief (lidocaine) Cream, 4% recall — FDA D-1858-2019
Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.
Class IIFDA: TerminatedRidge Properties, LLC
DrugSep 18, 2019
Pramipexole Dihydrochloride Tablets 0.125 mg,90-count bottle recall — FDA D-1851-2019
Subpotent Drug: Out of specification result during stability study in Pramipexole Dihydrochloride Tablets 0.125 mg
Class IIIFDA: TerminatedMacleods Pharma Usa Inc.
DrugSep 18, 2019
Bacteriostatic Water for Injection, USP, 30 mL vials recall — FDA D-1852-2019
Lack of Assurance of Sterility
Class IIFDA: TerminatedPfizer Inc.
How to use this drug recall index
A drug recall record can include the reason for recall, firm, status, distribution pattern, quantity and FDA classification. This site does not provide medical advice; it organizes public recall information and links users back to official sources.
Recall Lookup USA keeps the last complete source record available when an official data service is temporarily unavailable. When a source provides only a few fields, we show only those known facts rather than padding the page with generic text.
What the database can and cannot tell you
This database is designed for discovery and reference. It can help you locate a relevant recall record, identify the recalling firm or NHTSA campaign, compare dates and classifications, and follow the official source. It is not a substitute for a VIN-specific NHTSA check, a manufacturer notice, medical advice or instructions issued by the recalling company.